Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in AYA patients with and surviving childhood cancer.
Provision to sign and date the consent form.
Stated willingness to comply with all study procedures and be available for the duration of the study.
Be aged 15-24 years old at the time of enrollment
Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2)
Unable to read and speak English
Patients who did not receive cancer-directed therapy
Insufficient cognitive functioning to complete study measures, as determined by patient's
Participation in intervention development
University of Colorado, Denver
Lead sponsor
National Cancer Institute (NCI)
Collaborator